Cargando…

Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

PURPOSE: To evaluate the time course of biodegradation of an intracameral, biodegradable, sustained-release bimatoprost implant that lowers intraocular pressure without the need for daily eye drops. METHODS: In 2 identically designed, randomized, phase 3 clinical trials, adults with open-angle glauc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinreb, Robert N., Bacharach, Jason, Brubaker, Jacob W., Medeiros, Felipe A., Bejanian, Marina, Bernstein, Paula, Robinson, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885540/ https://www.ncbi.nlm.nih.gov/pubmed/36378864 http://dx.doi.org/10.1089/jop.2022.0137

Ejemplares similares

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)
por: Bacharach, Jason, et al.
Publicado: (2021)

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
por: Craven, E. Randy, et al.
Publicado: (2019)

Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
por: Seal, Jennifer R., et al.
Publicado: (2019)

Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients
por: Cordeiro, M Francesca, et al.
Publicado: (2015)

Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
por: Shen, Jie, et al.
Publicado: (2016)

Dose–Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure
por: Lee, Susan S., et al.
Publicado: (2019)

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
por: Day, Douglas G, et al.
Publicado: (2013)

Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
por: Goldberg, Ivan, et al.
Publicado: (2014)

Bimatoprost Implant: First Approval
por: Shirley, Matt
Publicado: (2020)

Correction to: Bimatoprost Implant: First Approval
por: Shirley, Matt
Publicado: (2020)

Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure
por: Tung, Jonathan D, et al.
Publicado: (2012)

The ARTEMIS mission
por: Russell, Christopher, et al.
Publicado: (2014)

Structure-Specific nuclease activities of Artemis and the Artemis: DNA-PKcs complex
por: Chang, Howard H.Y., et al.
Publicado: (2016)

Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant
por: Stamer, W. Daniel, et al.
Publicado: (2023)

Becoming Artemis’s Mother
por: McKinley, Sophia K.
Publicado: (2021)

Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension
por: Medeiros, Felipe A., et al.
Publicado: (2022)

Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost
por: Lee, Susan S., et al.
Publicado: (2019)

Bimatoprost in Dermatology
por: Jha, Abhijeet K., et al.
Publicado: (2018)

Nonclinical Pharmacokinetic and Pharmacodynamic Assessment of Bimatoprost Following a Single Intracameral Injection of Sustained-Release Implants
por: Shen, Jie, et al.
Publicado: (2020)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Bimatoprost in the treatment of eyelash hypotrichosis
por: Law, Simon K
Publicado: (2010)

Defective Artemis causes mild telomere dysfunction
por: Yasaei, Hemad, et al.
Publicado: (2010)

The Artemis Lunar Program: returning people to the Moon
por: von Ehrenfried, Manfred “Dutch”
Publicado: (2020)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Management of hypotrichosis of the eyelashes: Focus on bimatoprost
por: Fagien, Steven
Publicado: (2010)

The natural history of early-onset dementia: the Artemis Project
por: Atkins, Emily R, et al.
Publicado: (2012)

Comment on “Becoming Artermis’s Mother”: Becoming Artemis’s Bow
por: Kaslow, Sarah R.
Publicado: (2022)

Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
por: Ghosn, Corine, et al.
Publicado: (2022)

A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
por: Hartleben, Curt, et al.
Publicado: (2017)

Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
por: Shafiee, Afshin, et al.
Publicado: (2013)

Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
por: Xu, Kai Man, et al.
Publicado: (2022)

Floppy eyelid syndrome and ectropion improvement after 1 month of 0.03% Bimatoprost topical therapy
por: De Gregorio, Alessandra, et al.
Publicado: (2020)

Bimatoprost Effects on Aqueous Humor Dynamics in Monkeys
por: Woodward, David F., et al.
Publicado: (2010)

An Effect of Bimatoprost: Adverse for Some, Therapeutic for Others
por: Dubey, Ashok Kumar
Publicado: (2011)

Bimatoprost in the Treatment of Eyelash Universalis Alopecia Areata
por: Vila, Teresa Ojeda, et al.
Publicado: (2010)

The biodisposition and hypertrichotic effects of bimatoprost in mouse skin
por: Woodward, David F, et al.
Publicado: (2013)

Hirsutism following the use of bimatoprost eyedrops for glaucoma
por: Kaliaperumal, Subashini, et al.
Publicado: (2014)

Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
por: Chanasumon, Nongsak, et al.
Publicado: (2018)

Tear biomarkers in latanoprost and bimatoprost treated eyes
por: Reddy, Shweta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ske9g4ldvedqo5mincpml6n0d